Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dariusz Szukiewicz is active.

Publication


Featured researches published by Dariusz Szukiewicz.


Mediators of Inflammation | 2014

The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Piotr Wojdasiewicz; Łukasz A. Poniatowski; Dariusz Szukiewicz

Osteoarthritis (OA) is the most common chronic disease of human joints. The basis of pathologic changes involves all the tissues forming the joint; already, at an early stage, it has the nature of inflammation with varying degrees of severity. An analysis of the complex relationships indicates that the processes taking place inside the joint are not merely a set that (seemingly) only includes catabolic effects. Apart from them, anti-inflammatory anabolic processes also occur continually. These phenomena are driven by various mediators, of which the key role is attributed to the interactions within the cytokine network. The most important group controlling the disease seems to be inflammatory cytokines, including IL-1β, TNFα, IL-6, IL-15, IL-17, and IL-18. The second group with antagonistic effect is formed by cytokines known as anti-inflammatory cytokines such as IL-4, IL-10, and IL-13. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of OA with respect to inter- and intracellular signaling pathways is still under investigation. This paper summarizes the current state of knowledge. The cytokine network in OA is put in the context of cells involved in this degenerative joint disease. The possibilities for further implementation of new therapeutic strategies in OA are also pointed.


Advances in Medical Sciences | 2016

The role of sirtuins in aging and age-related diseases

Mateusz Wątroba; Dariusz Szukiewicz

Sirtuins, initially described as histone deacetylases and gene silencers in yeast, are now known to have much more functions and to be much more abundant in living organisms. Sirtuins gained much attention when they were first acknowledged to be responsible for some beneficial and longevity-promoting effects of calorie restriction in many species of animals - from fruit flies to mammals. In this paper, we discuss some detailed molecular mechanisms of inducing these effects, and wonder if they could be possibly mimicked without actually applying calorie restriction, through induction of sirtuin activity. It is known now that sirtuins, when adjusting the pattern of cellular metabolism to nutrient availability, can regulate many metabolic functions significant from the standpoint of aging research - including DNA repair, genome stability, inflammatory response, apoptosis, cell cycle, and mitochondrial functions. While carrying out these regulations, sirtuins cooperate with many transcription factors, including PGC-1a, NFKB, p53 and FoxO. This paper contains some considerations about possible use of facilitating activity of the sirtuins in prevention of aging, metabolic syndrome, chronic inflammation, and other diseases.


Gynecologic and Obstetric Investigation | 2005

Isolated Placental Vessel Response to Vascular Endothelial Growth Factor and Placenta Growth Factor in Normal and Growth-Restricted Pregnancy

Dariusz Szukiewicz; Grzegorz Szewczyk; Mateusz Watroba; Ewa Kurowska; S. Maslinski

Vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) cause vasodilation. We examined the vasomotor response of isolated placental vessels to VEGF and PlGF in normal (group I) and intrauterine growth retardation (IUGR)-complicated pregnancy (group II). Rings of vessels were prepared in vitro and mounted on the vessel myograph plunged in tissue bath. The magnitude of dilation to increased doses of VEGF and PlGF has been studied. VEGF is a more potent vasodilator than PlGF. Both, VEGF- and PlGF-induced vasorelaxation was diminished in the IUGR (group II) nearly by half, compared to control (group I). Relative placental nitric oxide deficiency, or decreased sensitivity to VEGF and PlGF may contribute to the development of high impedance fetoplacental circulation.


Oxidative Medicine and Cellular Longevity | 2016

Oxidative Stress and Mitochondrial Activation as the Main Mechanisms Underlying Graphene Toxicity against Human Cancer Cells

Anna Jarosz; Marta Skoda; Ilona Dudek; Dariusz Szukiewicz

Due to the development of nanotechnology graphene and graphene-based nanomaterials have attracted the most attention owing to their unique physical, chemical, and mechanical properties. Graphene can be applied in many fields among which biomedical applications especially diagnostics, cancer therapy, and drug delivery have been arousing a lot of interest. Therefore it is essential to understand better the graphene-cell interactions, especially toxicity and underlying mechanisms for proper use and development. This review presents the recent knowledge concerning graphene cytotoxicity and influence on different cancer cell lines.


Inflammation Research | 2008

Increased production of β-defensin 3 (hBD-3) by human amniotic epithelial cells (HAEC) after activation of toll-like receptor 4 in chorioamnionitis

Dariusz Szukiewicz; Grzegorz Szewczyk; M. Pyzlak; J. Klimkiewicz; D. Maslinska

Placenta and fetal membranes may become exposed to pathogenic microorganisms which may infl uence the embryo/fetus health. Recent investigations suggest that the placental unit may function as an active barrier, recognizing and responding to pathogens via toll-like receptors (TLRs) [1]. The TLR4 recognize lipopolysaccharide (LPS) microbial endotoxins associated with gram-negative bacteria. Various antimicrobial molecules are expressed on the surfaces of monocytes and epithelial cells [2]. Human amniotic epithelial cells (HAEC) produce antimicrobial β-defensins, especially human β-defensin 3 (hBD-3) [3]. Here we comparatively examined in vitro, infl uence of LPS on hBD-3 synthesis in normal HAEC and obtained after chorioamnionitis.


Journal of Nanomaterials | 2014

Graphene: one material, many possibilities—application difficulties in biological systems

Marta Skoda; Ilona Dudek; Anna Jarosz; Dariusz Szukiewicz

Energetic technologies, nanoelectronics, biomedicine including gene therapy, cell imaging or tissue engineering are only few from all possible applications for graphene, the thinnest known carbon configuration and a basic element for other more complicated, better discovered and widely used nanostructures such as graphite, fullerenes and carbon nanotubes. The number of researches concerning graphene applications is rising every day which proves the great interest in its unique structure and properties. Ideal pristine graphene sheet presents a flat membrane of unlimited size with no imperfections while in practice we get different flakes with irregular edges and structural defects which influence the reactivity. Nanomaterials from graphene family differ in size, shape, layer number, lateral dimension, surface chemistry and defect density causing the existence of graphene samples with various influence on biological systems. Whether graphene induces cellular stress and activates apoptosis, or on the contrary facilitates growth and differentiation of the cells depends on its structure, chemical modifications and the growth process. A certain number of in vitro studies has indicated cytotoxic effects of graphene while the other show that it is safe. The diversity of the samples and methods of the production make it impossible to establish clearly the biological impact of graphene.


Mediators of Inflammation | 2013

Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta

Dariusz Szukiewicz; Jan Kochanowski; M. Pyzlak; Grzegorz Szewczyk; Aleksandra Stangret; Tarun Kumar Mittal

Chemokine CX3CL1 is unique, possessing the ability to act as a dual agent: chemoattractant and adhesive compound. Acting via its sole receptor CX3CR1, CX3CL1 participates in many processes in human placental tissue, including inflammation and angiogenesis. Strongly upregulated by hypoxia and/or inflammation-induced inflammatory cytokines secretion, CX3CL1 may act locally as a key angiogenic factor. Both clinical observations and histopathological studies of the diabetic placenta have confirmed an increased incidence of hypoxia and inflammatory reactions with defective angiogenesis. In this study we examined comparatively (diabetes class C complicated versus normal pregnancy) the correlation between CX3CL1 content in placental tissue, the mean CX3CR1 expression, and density of the network of placental microvessels. A sandwich enzyme immunoassay was applied for CX3CL1 measurement in placental tissue homogenates, whereas quantitative immunohistochemical techniques were used for the assessment of CX3CR1 expression and the microvascular density. Significant differences have been observed for all analyzed parameters between the groups. The mean concentration of CX3CL1 in diabetes was increased and accompanied by augmented placental microvessel density as well as a higher expression of CX3CR1. In conclusion, we suggest involvement of CX3CL1/CX3CR1 signaling pathway in the pathomechanism of placental microvasculature remodeling in diabetes class C.


Inflammation Research | 2005

Mast cell-derived VEGF and VEGF receptor type 1, 2, and 3 expression in human term trophoblast culture—influence of hypoxia

Dariusz Szukiewicz; M. Gujski; D. Maslinska; Grzegorz Szewczyk; M. Bachanek; S. Maslinski

No Abstract..


Molecular Neurobiology | 2017

Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.

Łukasz A. Poniatowski; Piotr Wojdasiewicz; Maciej Krawczyk; Dariusz Szukiewicz; Robert Gasik; Łukasz Kubaszewski; Iwona Kurkowska-Jastrzębska

CX3CL1 (fractalkine) is the only member of the CX3C (delta) subfamily of chemokines which is unique and combines the properties of both chemoattractant and adhesion molecules. The two-form ligand can exist either in a soluble form, like all other chemokines, and as a membrane-anchored molecule. CX3CL1 discloses its biological properties through interaction with one dedicated CX3CR1 receptor which belongs to a family of G protein-coupled receptors (GPCR). The CX3CL1/CX3CR1 axis acts in many physiological phenomena including those occurring in the central nervous system (CNS), by regulating the interactions between neurons, microglia, and immune cells. Apart from the role under physiological conditions, the CX3CL1/CX3CR1 axis was implied to have a role in different neuropathologies such as traumatic brain injury (TBI) and spinal cord injury (SCI). CNS injuries represent a serious public health problem, despite improvements in therapeutic management. To date, no effective treatment has been determined, so they constitute a leading cause of death and severe disability. The course of TBI and SCI has two consecutive poorly demarcated phases: the initial, primary injury and secondary injury. Recent evidence has implicated the role of the CX3CL1/CX3CR1 axis in neuroinflammatory processes occurring after CNS injuries. The importance of the CX3CL1/CX3CR1 axis in the pathophysiology of TBI and SCI in the context of systemic and direct local immune response is still under investigation. This paper, based on a review of the literature, updates and summarizes the current knowledge about CX3CL1/CX3CR1 axis involvement in TBI and SCI pathogenesis, indicating possible molecular and cellular mechanisms with a potential target for therapeutic intervention.


Archivum Immunologiae Et Therapiae Experimentalis | 2016

The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.

Ilona Dudek; Marta Skoda; Anna Jarosz; Dariusz Szukiewicz

Graphene and graphene oxide (GO), due to their physicochemical properties and biocompatibility, can be used as an innovative biomedical material in biodetection, drug distribution in the body, treating neoplasms, regenerative medicine, and in implant surgery. Research on the biomedical use of graphene and GO that has been carried out until now is very promising and shows that carbon nanomaterials present high biocompatibility. However, the intolerance of the immune system to graphene nanomaterials, however low, may in consequence make it impossible to use them in medicine. This paper shows the specific mechanism of the molecular influence of graphene and GO on macrophages and lymphocytes under in vitro and in vivo conditions and their practical application in medicine. Under in vitro conditions graphene and GO cause an increased production of pro-inflammatory cytokines, mainly IL-1, IL-6, IL-10 and TNF-α, as a result of the activation of Toll-like receptors in macrophages. Graphene activates apoptosis in macrophages through the TGFbr/Smad/Bcl-2 pathway and also through JNK kinases that are stimulated by an increase of ROS in the cell or through a signal received by Smad proteins. Under in vivo conditions, graphene nanomaterials induce the development of the local inflammatory reaction and the development of granulomas in parenchymal organs. However, there is a huge discrepancy between the results obtained by different research groups, which requires a detailed analysis. In this work we decided to collect and analyze existing research and tried to explain the discrepancies. Understanding the precise mechanism of how this nanomaterial influences immune system cells allows estimating the potential influence of grapheme and GO on the human body.

Collaboration


Dive into the Dariusz Szukiewicz's collaboration.

Top Co-Authors

Avatar

Grzegorz Szewczyk

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

M. Pyzlak

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

D. Maslinska

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Aleksandra Stangret

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

S. Maslinski

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

J. Klimkiewicz

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Marta Skoda

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Tarun Kumar Mittal

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Ilona Dudek

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Krzysztof Cendrowski

Medical University of Warsaw

View shared research outputs
Researchain Logo
Decentralizing Knowledge